GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MAKO Surgical Corporation (FRA:4M6) » Definitions » Accounts Receivable

MAKO Surgical (FRA:4M6) Accounts Receivable : €12.25 Mil (As of Sep. 2013)


View and export this data going back to . Start your Free Trial

What is MAKO Surgical Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. MAKO Surgical's accounts receivables for the quarter that ended in Sep. 2013 was €12.25 Mil.

Accounts receivable can be measured by Days Sales Outstanding. MAKO Surgical's Days Sales Outstanding for the quarter that ended in Sep. 2013 was 65.67.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. MAKO Surgical's Net-Net Working Capital per share for the quarter that ended in Sep. 2013 was €0.60.


MAKO Surgical Accounts Receivable Historical Data

The historical data trend for MAKO Surgical's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MAKO Surgical Accounts Receivable Chart

MAKO Surgical Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.02 4.48 8.74 15.80 17.06

MAKO Surgical Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.21 17.06 11.67 16.02 12.25

MAKO Surgical Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


MAKO Surgical Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

MAKO Surgical's Days Sales Outstanding for the quarter that ended in Sep. 2013 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=12.254/17.026*91
=65.67

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), MAKO Surgical's accounts receivable are only considered to be worth 75% of book value:

MAKO Surgical's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2013 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(39.552+0.75 * 12.254+0.5 * 18.393-29.604
-0-0)/47.1891
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


MAKO Surgical Accounts Receivable Related Terms

Thank you for viewing the detailed overview of MAKO Surgical's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


MAKO Surgical (FRA:4M6) Business Description

Traded in Other Exchanges
N/A
Address
MAKO Surgical Corporation was incorporated in Delaware in November 2004. The Company is a medical device company that markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures. It offers MAKOplasty, an innovative, restorative surgical solution that enables orthopedic surgeons to consistently, reproducibly and precisely treat patient specific, osteoarthritic disease. The Company currently offers MAKOplasty Partial Knee Arthroplasty, or MAKOplasty PKA, and MAKOplasty Total Hip Arthroplasty, or MAKOplasty THA. MAKOplasty PKA, which requires extraction and replacement of the entire joint, enables resurfacing of one or two specific diseased compartments of the joint, preserving significantly more soft tissue and healthy bone of the knee. MAKOplasty procedures are enabled through its proprietary technology consisting of the components which includes its RIO system, its MAKOplasty applications, and its RESTORIS family of implant systems. The centerpiece of MAKOplasty is the RIO system, its proprietary robotic arm, interactive, orthopedic system, that provides both pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal and accurate implant insertion and alignment. The RIO system consists of two elements: a tactile robotic arm utilizing an integrated bone cutting instrument and a patient specific visualization component. The RIO system, version 2.0 of its Tactile Guidance System, or TGS, represents an important expansion from its first generation TGS, enabling and expanding the MAKOplasty PKA application to multicompartmental resurfacing procedures, allowing orthopedic surgeons to treat degenerative knee osteoarthritis from early-stage, unicompartmental degeneration through mid-stage, multicompartmental degeneration with a modular knee implant system, as well as enabling the MAKOplasty THA application. The Company's MAKOplasty PKA application enables surgeons to isolate and resurface just one or two specific diseased compartments of the joint through a minimally invasive incision, preserving significantly more soft tissue and healthy bone of the knee. The MAKOplasty knee resurfacing procedure is performed by the surgeon using the surgical planning and execution software integrated into its patient specific visualization system. The Company's MAKOplasty THA application utilizes the RIO system's tactile, visual and auditory feedback to assist the surgeon in preparing the acetabulum (hip socket) for optimal placement of the acetabular cup implant. The MAKOplasty THA application allows the surgeon to preoperatively plan the placement of the hip implants on a three dimensional image of a pre-operative CT scan. Its RESTORIS family of knee implants is designed to enable minimally invasive restoration of one or two of the diseased compartments of the knee joint. Its RESTORIS family of knee implants for use in si

MAKO Surgical (FRA:4M6) Headlines

No Headlines